Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308692356> ?p ?o ?g. }
- W4308692356 abstract "Abstract Background The effectiveness of neoadjuvant immune checkpoint inhibition (ICI) therapy has been confirmed by clinical trials; however, patients that are suitable for receiving this therapy remain unspecified. Previous studies have demonstrated that the tumor microenvironment (TME) dominates immunotherapy; therefore, an effective classification strategy for the TME is needed. Methods Five publicly available datasets (n = 1,426) were used to identify the immunophenotypic features of the TME and to screen for core molecules. The training cohort (n = 506) was used to construct the immunophenotypic score (IPS) and six independent external centers (n = 638) were recruited as validation. Besides, 52 patients with GC receiving neoadjuvant anti-PD-1 therapy was enrolled to explore the value of the IPS in neoadjuvant ICI therapy. Moreover, the IPS-specific TME was profiled by multiplexed immunohistochemical staining and immunohistochemical staining. Results Five immunophenotype-related features (WARS, UBE2L6, GZMB, BATF2, and LAG-3) associated with prognosis and the immunotherapeutic response in GC were identified, forming the IPS. The data from seven medical centers (n = 1,144) indicated that the IPS is a robust and independent biomarker for GC and superior to the traditional TNM stage. Furthermore, IPS Low was defined as the immune-activated tumor that benefited from neoadjuvant anti-PD-1 therapy, while IPS High exhibited more immune unresponsive signals. Notably, patients with IPS Low and PD-L1 (CPS) ≥ 5 were observed to be the most favorable group for neoadjuvant anti-PD-1 treatment. Conclusions The IPS could serve as a valid quantitative tool for immunophenotyping to improve clinical outcomes, and it provides an effective reference for the implementation of neoadjuvant ICI therapy for patients with GC." @default.
- W4308692356 created "2022-11-14" @default.
- W4308692356 creator A5001432963 @default.
- W4308692356 creator A5002281586 @default.
- W4308692356 creator A5019806453 @default.
- W4308692356 creator A5019887424 @default.
- W4308692356 creator A5031251029 @default.
- W4308692356 creator A5035633007 @default.
- W4308692356 creator A5035701638 @default.
- W4308692356 creator A5043039345 @default.
- W4308692356 creator A5044082173 @default.
- W4308692356 creator A5057347003 @default.
- W4308692356 creator A5058103854 @default.
- W4308692356 creator A5060735508 @default.
- W4308692356 creator A5063131315 @default.
- W4308692356 creator A5071174475 @default.
- W4308692356 creator A5072823040 @default.
- W4308692356 creator A5073070877 @default.
- W4308692356 creator A5073199916 @default.
- W4308692356 creator A5077153850 @default.
- W4308692356 creator A5078507731 @default.
- W4308692356 date "2022-11-10" @default.
- W4308692356 modified "2023-10-17" @default.
- W4308692356 title "Tumor immunophenotyping-derived signature identifies prognosis and neoadjuvant immunotherapeutic responsiveness in gastric cancer" @default.
- W4308692356 cites W1944707476 @default.
- W4308692356 cites W1980137951 @default.
- W4308692356 cites W1981352048 @default.
- W4308692356 cites W1985987855 @default.
- W4308692356 cites W2019607817 @default.
- W4308692356 cites W2021329831 @default.
- W4308692356 cites W2039123767 @default.
- W4308692356 cites W2066671159 @default.
- W4308692356 cites W2070555748 @default.
- W4308692356 cites W2079936875 @default.
- W4308692356 cites W2115462905 @default.
- W4308692356 cites W2116634113 @default.
- W4308692356 cites W2124427232 @default.
- W4308692356 cites W2136731993 @default.
- W4308692356 cites W2146512944 @default.
- W4308692356 cites W2162222767 @default.
- W4308692356 cites W2294356527 @default.
- W4308692356 cites W2338576144 @default.
- W4308692356 cites W2578528809 @default.
- W4308692356 cites W2725398806 @default.
- W4308692356 cites W2763933536 @default.
- W4308692356 cites W2769419513 @default.
- W4308692356 cites W2785934310 @default.
- W4308692356 cites W2793364080 @default.
- W4308692356 cites W2890875511 @default.
- W4308692356 cites W2897815318 @default.
- W4308692356 cites W2907564726 @default.
- W4308692356 cites W2913383852 @default.
- W4308692356 cites W2920600229 @default.
- W4308692356 cites W2920863623 @default.
- W4308692356 cites W2963686803 @default.
- W4308692356 cites W3003310139 @default.
- W4308692356 cites W3009140068 @default.
- W4308692356 cites W3047106569 @default.
- W4308692356 cites W3110797703 @default.
- W4308692356 cites W3132811153 @default.
- W4308692356 cites W3166392727 @default.
- W4308692356 cites W3168239748 @default.
- W4308692356 cites W3168540735 @default.
- W4308692356 cites W3195744482 @default.
- W4308692356 cites W3201363819 @default.
- W4308692356 cites W4200339743 @default.
- W4308692356 cites W4205506118 @default.
- W4308692356 cites W4206384216 @default.
- W4308692356 cites W4210511445 @default.
- W4308692356 cites W4220909053 @default.
- W4308692356 cites W4225394054 @default.
- W4308692356 cites W4280599663 @default.
- W4308692356 cites W4281732693 @default.
- W4308692356 doi "https://doi.org/10.21203/rs.3.rs-2248043/v1" @default.
- W4308692356 hasPublicationYear "2022" @default.
- W4308692356 type Work @default.
- W4308692356 citedByCount "0" @default.
- W4308692356 crossrefType "posted-content" @default.
- W4308692356 hasAuthorship W4308692356A5001432963 @default.
- W4308692356 hasAuthorship W4308692356A5002281586 @default.
- W4308692356 hasAuthorship W4308692356A5019806453 @default.
- W4308692356 hasAuthorship W4308692356A5019887424 @default.
- W4308692356 hasAuthorship W4308692356A5031251029 @default.
- W4308692356 hasAuthorship W4308692356A5035633007 @default.
- W4308692356 hasAuthorship W4308692356A5035701638 @default.
- W4308692356 hasAuthorship W4308692356A5043039345 @default.
- W4308692356 hasAuthorship W4308692356A5044082173 @default.
- W4308692356 hasAuthorship W4308692356A5057347003 @default.
- W4308692356 hasAuthorship W4308692356A5058103854 @default.
- W4308692356 hasAuthorship W4308692356A5060735508 @default.
- W4308692356 hasAuthorship W4308692356A5063131315 @default.
- W4308692356 hasAuthorship W4308692356A5071174475 @default.
- W4308692356 hasAuthorship W4308692356A5072823040 @default.
- W4308692356 hasAuthorship W4308692356A5073070877 @default.
- W4308692356 hasAuthorship W4308692356A5073199916 @default.
- W4308692356 hasAuthorship W4308692356A5077153850 @default.
- W4308692356 hasAuthorship W4308692356A5078507731 @default.
- W4308692356 hasBestOaLocation W43086923561 @default.
- W4308692356 hasConcept C121608353 @default.
- W4308692356 hasConcept C126322002 @default.